Get access to our best features
Get Started
SubscribeLogin
Get access to our best features
Get Started
Published

Commercial Spillover Impact of Part B Negotiations on Physicians

Summary by Avalere Health
The Medicare Drug Negotiation Program (MDNP) established under the Inflation Reduction Act (IRA) allows the Centers for Medicare & Medicaid Services (CMS) to negotiate Maximum Fair Prices (MFPs) for a subset of high-spend drugs. MFPs for the first 10 Part D negotiated products will take effect in 2026. Starting in 2028, physician-administered drugs covered under Part B will also be included in the MDNP. On August 15, CMS announced the final MFPs…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Inflation Reduction Act

Inflation Reduction Act

Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2025 Snapwise Inc
News
For You
Search
BlindspotLocal